Loo Stephanie Jyet Quan, Wong Nyet Kui
Division of Applied Biomedical Sciences and Biotechnology, School of Health Sciences, International Medical University, Kuala Lumpur 57000, Malaysia.
Biomed Rep. 2021 Aug;15(2):67. doi: 10.3892/br.2021.1443. Epub 2021 Jun 10.
Osteoarthritis (OA) is a degenerative disorder of the cartilage and is one of the leading causes of disability, particularly amongst the elderly, wherein patients with advanced-stage OA experience chronic pain and functional impairment of the limbs, thus resulting in a significantly reduced quality of life. The currently available treatments primarily revolve around symptom management, and is thus palliative rather than curative. The aim of the present review is to briefly discuss the limitations of some of the currently available treatments for patients with OA, and highlight the value of the potential use of stem cells in cellular therapy, which is widely regarded as the breakthrough that can address the present unmet medical needs for treatment of degenerative diseases, such as OA. The advantages of stem cell therapy, particularly mesenchymal stem cells, and the challenges involved are also discussed in this review.
骨关节炎(OA)是一种软骨退行性疾病,是导致残疾的主要原因之一,尤其是在老年人中。晚期OA患者会经历慢性疼痛和肢体功能障碍,从而导致生活质量显著下降。目前可用的治疗方法主要围绕症状管理,因此是姑息性而非治愈性的。本综述的目的是简要讨论目前一些针对OA患者的可用治疗方法的局限性,并强调干细胞在细胞治疗中的潜在应用价值,干细胞疗法被广泛认为是能够满足目前对退行性疾病(如OA)治疗未满足的医疗需求的突破。本综述还讨论了干细胞治疗的优势,特别是间充质干细胞的优势以及所涉及的挑战。